{"nct_id":"NCT00831467","title":"Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2009-01","start_date_type":null,"primary_completion_date":"2009-12","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["CVAC"]}